[1] OKUNADE KS.Human papillomavirus and cervical cancer [J].Journal of Obstetrics and Gynaecology,2020,40(5):602-608.
[2] 丁鑫,王乾印,马亮亮,等.106例宫颈癌患者术后预后生存质量调查及预后COX回归分析 [J].中国妇产科临床杂志,2022,23(03):318-319.
DING X,WANG QY,MA LL,et al.Analysis of postoperative prognosis and quality of life in 106 patients with cervical cancer [J].Chinese Clinical Journal of Obstetrics and Gynecology,2022,23(03):318-319.
[3] UNGUREANU C,SOCOLOV DG,ANTON G,et al.Role of ProEx C immunocytochemistry in cervical high-grade squamous intraepithelial lesions detection [J].Romanian Journal of Morphology and Embryology,2021,62(4):1029-1034.
[4] WANG R,PAN W,JIN L,et al.Human papillomavirus vaccine against cervical cancer:Opportunity and challenge [J].Cancer Letters,2020,471:88-102.
[5] 江星元,刘应南,陶霞.HPV E6/E7在宫颈病变恶性进展或宫颈癌复发中的预测作用[J].中国妇产科临床杂志,2020,21(01):97-99.
JIANG XY,LIU YN,TAO X.The role of HPV E6/E7 in predicting the progression of cervical cancer and the recurrence of cervical cancer [J].Chinese Journal of Obstetrics and Gynecology,2020,21(01):97-99.
[6] ZHANG R,LU H,LYU YY,et al.E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway [J].Scientific Reports,2017,7,44744.
[7] GUPTA S,KUMAR P,DAS BC.HPV:Molecular pathways and targets [J].Current Problems in Cancer,2018,42(2):161-174.
[8] ZHOU Y,XU J,LUO H,et al.Wnt signaling pathway in cancer immunotherapy [J].Cancer Letters,2022,525,84-96.
[9] CHENG X,XU X,CHEN D,et al.Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer [J].Biomedicine & Pharmacotherapy,2019,110,473-481.
[10]GAJOS-MICHNIEWICZ A,CZYZ M.WNT Signaling in Melanoma [J].International Journal of Molecular Sciences,2020,21(14):4852.
[11] SUKSWAI N,KHOURY JD.Immunohistochemistry innovations for diagnosis and tissue-based biomarker detection [J].Current Hematologic Malignancy Reports,2019,14(5):368-375.
[12] CHENG L,WANG Q,TAO X,et al.FOXM 1 induces vasculogenic mimicry in esophageal cancer through β-catenin /Tcf4 signaling [J].Diagnostic Pathology,2020,15(1):14.
[13] LIANG J,ZHOU H,PENG Y,et al.β-Catenin expression negatively correlates with WIF1 and predicts poor clinical outcomes in patients with cervical cancer [J].BioMed Research International,2016,2016,4923903.
[14] XIE Q,TANG T,PANG J,et al.LSD1 promotes bladder cancer progression by upregulating LEF1 and enhancing EMT [J].Frontiers in Oncology,2020,10,1234.
[15] FREIHEN V,RONSCH K,MASTROIANNI J,et al.SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation [J].International Journal of Cancer,2020,146(8):2229-2242.
[16] LIANG J,LI Y,DANIELS G,et al.LEF1 targeting EMT in prostate cancer invasion is regulated by miR-34a [J].Molecular Cancer Research:MCR,2015,13(4):681-688.
[17]BERNDT SI,SKIBOLA CF,JOSEPH V,et al.Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia [J].Nature Genetics,2013,45(8):868-876.
[18] 杨大磊,唐娜,徐洪涛,等.肺癌组织TC-1和β-catenin表达临床意义研究 [J].中华肿瘤防治杂志,2014,21(10):753-756.
YANG DL,TANG N,XU HT,et al.Clinical significance of expression of TC-1 and β-catenin in lung cancer [J].Chinese Journal of Cancer Prevention,2014,21(10):753-756.
[19] 郑炎,肖大树,朱楠,等.乳腺癌中β-catenin的表达及临床意义[J].临床与实验病理学杂志,2021,37(03):275-278.
ZHENG Y,XIAO DS,ZHU N,et al.Expression and clinical significance of β-catenin in breast cancer [J].Chin J Clinical and Experimental Pathology,2021,37(03):275-278.
[20] 米优嘉,原翔,贾瑞诺,等.食管鳞状细胞癌组织中β-catenin、LEF1的表达变化及其意义 [J].山东医药,2021,61(12):47-50.
MI YJ,YUANG X,JIA RN,et al.Expression changes of β-catenin and LEF1 in esophageal squamous cell carcinoma and their significance [J].Shandong Medical Journal,2021,61(12):47-50.
[21] 刘燕,朱莉,田冰.宫颈癌组织中Zac1和LEF1的表达及临床意义 [J].国际检验医学杂志,2022,43(10):1216-1220.
LIU Y,ZHU L,TIAN B.Expression and clinical significance of Zacl and LEF1 in cervical cancer tissues[J].International Journal of Laboratory Medicine,2022,43(10):1216-1220.
[22] FANG L,ZHU Q,NEUENSCHWANDER M,et al.A small-molecule antagonist of the β-Catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis [J].Cancer Research,2016,76(4):891-901.
[23] HOVANES K,LI TW,MUNGUIA JE,et al.Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer [J].Nature Genetics,2001,28(1):53-57.